Ernst & Young LLP

News & Analysis

biotechnology and ernst & young llp - All News and Analysis

• NJ Biotechnology Industry Survey Sees Growth and Maturity

  - 2008-06-30

  Number of New Jersey Companies Continues to Increase Increases Also Seen in Employees, R&D Spending and Revenues; Early-Stage Funding Remains an Issue TRENTON, N.J. -- New Jersey's biotechnology industry continued to both grow and mature in 2007, according to the latest BioNJ industry survey. The industry expanded as...

  Tags: Biotechnology, Editor, Ernst & Young LLP, M&A, survey

• Biotechnology Pioneer Jean-Paul Clozel Named Ernst & Young World Entrepreneur Of The Year 2008

  - 2008-06-01

  MONTE CARLO, Monaco -- Dr. Jean-Paul Clozel, founder of Switzerland's Actelion Pharmaceuticals Ltd., a pioneering biotechnology company, was last night named the Ernst & Young World Entrepreneur Of The Year 2008 at an awards ceremony held in Monte Carlo's Salle des Etoiles. Clozel was picked from among entrepreneurs representing more...

  Tags: biotechnology, Ernst & Young LLP

• Biotechnology

  - 2007-04-30

  According to a new report from Ernst & Young, the US biotech industry is at its strongest. Deals among US companies reached a total of $23 billion last year, and the value of mergers and acquisitions was at its second-highest level in the industry's history. Venture capital hit an all-time...

  Tags: Biotechnology, CEO, Ernst & Young LLP, FINANCE, Investment, M&A, revenue

• N.C. in big 3 again

  - 2006-05-01

  North Carolina maintained its third-place hold on the biotechnology hierarchy in 2005, according to the 20th anniversary 2006 edition of the annual Ernst & Young global biotechnology report. The report, "Beyond Borders," was unveiled for a global audience during the Bio 2006 conference in Chicago in April. More specific...

  Tags: Biotechnology, Ernst & Young LLP

• Southeastern States Continue Climb in Biotech Rankings

  - 2006-04-20

  CHARLOTTESVILLE, Va. -- Southeastern states continue to climb in major biotech rankings. The most recent evidence is provided by Ernst & Young's Beyond Borders: The Global Biotechnology Report 2006, which reveals that three Southeastern states - North Carolina, Georgia and Florida - are among the top ten U.S. biotech centers....

  Tags: Biotechnology, Ernst & Young LLP, Florida, Georgia

• Awarding career: George Ayoub, CEO of Canoga Park's One Lambda and one of Ernst & Young's Entrepreneurs of the Year, has been a pioneer of the area's biotech industry

  - 2005-07-18

  George Ayoub got the chance to work with one of the pioneers in transplant research, Paul Terasaki, while he was a researcher at UCLA. In 1980, the field Terasaki had helped to create was deregulated and private businesses started entering it. Rather than see the science taken over by other...

  Tags: Biotechnology, career, DNA, Ernst & Young LLP, University of California at Los Angeles

• Public biotechs see revenues jump over 2003 figures: Sarbanes-Oxley, drug safety issues contribute to record net losses

  - 2005-06-06

  Revenues at publicly traded biotechnology companies jumped 17 percent nationwide, while the number at locally traded biotechs climbed 20 percent, according to a global biotech report by Ernst & Young LLR The report, released late last week, also revealed total revenue at publicly traded biotechs rose to $54.6 billion...

  Tags: accounting, Biotechnology, Ernst & Young LLP, FDA, revenue

• Md. biotechs fourth in Ernst & Young's annual ranking

  - 2005-06-06

  After falling from its third-place perch last year, Maryland held onto fourth place in Ernst & Young's annual ranking of state's with the highest concentration of biotechnology companies.

  Tags: biotechnology, Ernst & Young LLP

• Bio-IT World Conference + Expo to Explore the Venture Capital Landscape for Bio-IT and Biopharma Industries

  - 2005-04-13

  FRAMINGHAM, Mass. -- Ernst & Young and IDG Ventures to host Venture Forum; Lawrence J. Lesko of the FDA added to keynote lineup IDG World Expo, the leading producer of world-class tradeshows, conferences and events for technology markets, today announced the agenda for the "Venture Forum" at Bio-IT World...

  Tags: biotechnology, conference, Ernst & Young LLP, FDA, Government, HEALTHCARE, International Data Group

• San Diego firms get more VC funds in '04; Gen-Probe to record $1.9 million in license revenue in first quarter

  - 2005-01-31

  There was a slight increase in venture capital funding into San Diego's biotechnology companies from 2003 to 2004, according to a survey released by accounting firm Ernst & Young and Venture One, a unit of Dow Jones Newswires and publisher of VentureSource. But the level of venture capital investment,...

  Tags: biotechnology, Ernst & Young LLP, FINANCE, Investment